Fingerprint
Dive into the research topics of 'Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically